Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients

Sponsor
CHU de Quebec-Universite Laval (Other)
Overall Status
Completed
CT.gov ID
NCT02837822
Collaborator
(none)
38
2
2
31
19
0.6

Study Details

Study Description

Brief Summary

It's well known that Spinal cord stimulation (SCS) changes the perception of chronic pain in the area stimulated by epidural electrodes. However, we don't know the effect of this type of stimulation on the perception of external sensations (temperature, touch, pressure, and vibration) and sharp pain. Quantitative sensory testing (QST) is used to quantify somatosensory phenotype. This QST battery tests different subtypes of nerve fibres (Aβ, Aδ and C) involved in the transduction of sensory information from the periphery to the spinal cord.

The purpose of this study is to evaluate the effects of the SCS on sensory perceptions of patients with chronic pain (CRPS, FBSS). Sensorial perception tests will be carried out in accordance with a standardized procedure (Rolke et al. Pain, 2006). For non-implanted patients, an initial visit will be conducted before the operation. For all participants, two other visits will take place at least 6 months after the operation to perform the tests with and without stimulation.

Condition or Disease Intervention/Treatment Phase
  • Device: Spinal cord stimulator
  • Procedure: Implantation of a spinal cord stimulator
N/A

Detailed Description

Spinal cord stimulation (SCS) is a reversible and minimally invasive neuromodulation technique employs for the treatment of chronic neuropathic pain. Even if SCS is an established technology for the management of complex regional pain syndrome (CRPS) and failed back surgery syndrome (FBSS), its impacts on the sensory perception system remain misunderstood.

The purpose of this study is to evaluate the effects of the SCS on sensory perceptions of patients with chronic pain (CRPS, FBSS). Sensorial perception tests will be carried out in accordance with a standardized procedure (Rolke et al. Pain, 2006) at the level of maximum pain area (painful leg), and at two non-painful areas (contralateral leg and ipsilateral arm). The thermode "Thermal Sensory Analyser TSA-II NeuroSensory Analyzer" and its complement "Vibratory Sensory Analyzer VSA-3000" (Medoc) will be used to assess warm, cold and vibratory detection thresholds, as well as heat and cold painful thresholds. Von Frey monofilaments (Bioseb) will be used to evaluate the mechanical detection threshold. The algometer "Force Ten ™ FDX Digital" (Wagner) will measure the pressure pain threshold. Dynamic mechanical allodynia will be assessed with a standardized brush (SENSELab Brush-05, Somedic). The Neuropen (Owen Mumford) will be used to test the temporal pain summation. Participants will be recruited through the neuromodulation clinic located in Enfant-Jésus Hospital (Québec, Canada).

For non-implanted patients, an initial visit will be conducted before the operation. For all participants, two other visits will take place at least 6 months after the operation to perform the tests with and without stimulation (the order of these visits will be randomized).

For each test, an average of the absolute differences (with-without stimulation) and its confidence interval will be calculated. The results will be considered significant with p values inferior to 0,05. All analyzes will be performed with SAS (SAS 9.3 Institute Inc, Cary, NC, USA).

The protocol was peer reviewed and approved by the Ethics Committee of Enfant-Jésus Hospital. All subjects will participate after written informed consent.

Study Design

Study Type:
Interventional
Actual Enrollment :
38 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients
Study Start Date :
Oct 1, 2015
Actual Primary Completion Date :
May 1, 2018
Actual Study Completion Date :
May 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Stimulation Off

Patients receiving the intervention "implantation with a spinal cord stimulator". The system is turn Off during the experiment.

Device: Spinal cord stimulator
Spinal cord stimulator is a reversible and minimally invasive neuromodulation device used for the treatment of various diseases related to chronic pain, including CRPS and FBSS. Briefly, this technology uses electrical pulses to generate action potentials in nerve cells that induce paresthesias (buzzing or tingling sensations) in the affected limb and can relieve pain.
Other Names:
  • Dorsal column stimulation
  • Procedure: Implantation of a spinal cord stimulator
    The electrical pulses are induced by one or more electrodes surgically implanted into the epidural space. These electrodes are usually placed under the skin in the abdomen or upper buttock.

    Active Comparator: Stimulation On

    Patients receiving the intervention "implantation with a spinal cord stimulator". The system is turn On during the experiment.

    Device: Spinal cord stimulator
    Spinal cord stimulator is a reversible and minimally invasive neuromodulation device used for the treatment of various diseases related to chronic pain, including CRPS and FBSS. Briefly, this technology uses electrical pulses to generate action potentials in nerve cells that induce paresthesias (buzzing or tingling sensations) in the affected limb and can relieve pain.
    Other Names:
  • Dorsal column stimulation
  • Procedure: Implantation of a spinal cord stimulator
    The electrical pulses are induced by one or more electrodes surgically implanted into the epidural space. These electrodes are usually placed under the skin in the abdomen or upper buttock.

    Outcome Measures

    Primary Outcome Measures

    1. Change in sensory thresholds [Baseline and at least 6 months post-implantation]

      Sensorial perception tests will be carried out in accordance with a standardized procedure (Rolke et al. Pain, 2006). The thermode "Thermal Sensory Analyser TSA-II NeuroSensory Analyzer" and its complement "Vibratory Sensory Analyzer VSA-3000" (Medoc) will be used to assess warm, cold and vibratory detection thresholds, as well as heat and cold painful thresholds. Von Frey monofilaments (Bioseb) will be used to evaluate the mechanical detection threshold. The algometer "Force Ten ™ FDX Digital" (Wagner) will measure the pressure pain threshold. Dynamic mechanical allodynia will be assessed with a standardized brush (SENSELab Brush-05, Somedic). The Neuropen (Owen Mumford) will be used to test the temporal pain summation.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Participant with a diagnosis of CRPS or FBSS that meet International Association for the Study of Pain's criteria;

    • Pain in one leg;

    • Paresthesia area limited to the treated leg;

    • No changes in the programming patterns of the device for a minimum of 30 days before the tests;

    • Informed consent.

    Exclusion Criteria:
    • Wounds or infections at the painful site.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Toledo Medical Center Toledo Ohio United States 43614
    2 CHU de Québec - Université Laval Québec Canada G1J 1Z4

    Sponsors and Collaborators

    • CHU de Quebec-Universite Laval

    Investigators

    • Principal Investigator: Michel Prud'Homme, MD, PhD, Chu de Québec - Université Laval

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Michel Prud'Homme, MD, PhD, CHU de Quebec-Universite Laval
    ClinicalTrials.gov Identifier:
    NCT02837822
    Other Study ID Numbers:
    • 2015-2072
    First Posted:
    Jul 20, 2016
    Last Update Posted:
    Jul 17, 2018
    Last Verified:
    Jul 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Keywords provided by Michel Prud'Homme, MD, PhD, CHU de Quebec-Universite Laval
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 17, 2018